FindTrial
Sign In

comparision of two drugs in allergic eye disease

Tacrolimus 0.1% as an alternative to Loteprednol 0.5% in the management of nummular keratitis - a pilot study in 100 cases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027087
Enrollment
100
Registered
2020-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H188- Other specified disorders of cornea

Interventions

Intervention1: tacrolimus 0.1% eye ointment: tacrolimus eye ointment was uesd daily at bed time for 2 months Control Intervention1: loteprednol 0.5% eye drops: loteprednol 0.5% eye drops 4 times per d

Sponsors

Srikiran eye institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with nummular keratitis in one or both eyes.

Exclusion criteria

Exclusion criteria: age less than 10 years and more than 75 years,one eyed, other complicating eye diseases

Design outcomes

Primary

MeasureTime frame
symptomatic relief and reduction in signsTimepoint: 1 week, 2 weeks, 1 month 2months—

Secondary

MeasureTime frame
disappearence of scarTimepoint: 1 month, 3 months, 6 months—

Countries

India

Contacts

Public ContactDr madhu uddaraju

srikiran eye hospital

eyedrmadhu@gmail.com9676743333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026